Thyroid News

Among adults with thyrotoxicosis and associated complications, risk for hospitalization is higher among those without health insurance and lower for those with higher education and higher median income, according to findings published in Thyroid.

Among patients with heart failure, levothyroxine therapy may increase risk for all-cause death, major adverse cardiovascular events and CV death, independent of whether the patient is treated before or after the heart failure diagnosis, according to an analysis of Danish registry data.

Endocrine Today has compiled a list of the top five news reports posted in September. Healio.com/Endocrinology readers were interested in diet’s effect on thyroid function, the ‘Know Diabetes by Heart’ initiative and menopause’s interaction with sleep.

Many thyroid cancers detected by ultrasound screening in Japanese children in the 5 years after the 2011 Fukushima Daiichi nuclear accident mirror many low-risk, sporadic cases of adult thyroid cancer and are most likely not associated with radiation exposure, according to findings published in JAMA Otolaryngology Head & Neck Surgery.

Medical treatment for autoimmune thyroid disease, an infection requiring hospitalization or the development of retinopathy should “raise the suspicion” of Addison’s disease development in adults with type 1 diabetes, according to findings from a registry-based study conducted in Sweden.

CHICAGO — Patients with elevated free thyroxine levels — still within what is considered the normal range — may be at greater risk for atrial fibrillation than those with lower levels, according to findings presented at the American Heart Association Scientific Sessions.

SAN FRANCISCO — VK2809, a thyroid receptor beta agonist, showed an impact on nearly all treated patients as measured by magnetic resonance imaging-proton density fat fraction, according to late breaking data presented at The Liver Meeting 2018.

Among those with type 1 diabetes, white adults and women are at a significantly higher risk for developing additional autoimmune diseases as they age vs. other subgroups, according to findings published in the Journal of Diabetes.

High levels of thyrotropin are linked to a decrease in brain volume, and even subclinical hypothyroidism may lead to reduced hippocampal volume, according to findings published in Thyroid.

The novel tyrosine kinase inhibitor anlotinib was shown to provide adequate therapeutic benefits for tumor reduction in adults with locally advanced and metastatic medullary thyroid carcinoma, according to findings from a phase 2 clinical trial published in Thyroid.